Back to News
Market Impact: 0.2
Wendy's Board Blocks Peltz's Buyout with Poison Pill
Source: zacks.com
M&A & RestructuringShort Interest & ActivismManagement & GovernanceCompany Fundamentals
Wendy’s leadership rejected Trian’s bid and enacted a defensive poison pill, signaling confidence in the company’s standalone turnaround plan. The article provides no bid terms, financial figures, or market reaction.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment
WEN0.40
More News
- Wendy's rejects takeover proposal from Nelson Peltz’s Trian
- Wendy’s Rejects Takeover Bid From Peltz's Trian
- Wendy’s rejects $1.4 billion Trian buyout offer, adopts poison pill defense
- Robo Block Shows China’s Long Reach in M&A
- Wendy's 'no' to Peltz may be a bigger gamble than investors realize
- Stocks making the biggest moves premarket: Shake Shack, Wendy's, Peloton, Unity Software & more